Olymvax Biopharmaceuticals Inc

Business Type:Manufacturer

Main Products:Tetanus Vaccine adsorbed,Haemophilus influenzae type b Conjugate Vaccine,Group A and C Meningococcal Conjugate Vaccine,MenAC-Hib Combined Vaccine

Total Employees:101-500

Country/Region:China

Year Established:2009

Ddu Verified

HOT Rank

8/10
Leave a message
Company Information

Founded in 2009, Olymvax Biopharmaceuticals Inc. is a High-tech enterprise, focusing on the R&D, production and marketing of human-use vaccines. Its registered capital is 205.68 million CNY. The factory covers an area of 5.4 acres, with 77,000 m2 (828,800 square feet) in the construction plan and 39,000 m2 already finished. Up to the end of December, 2018, the company had 221 employees, among which, 14 have a master's degree or above, accounting for 6.33% of the associates.

Email to this supplier
To

Send

Inquiry Cart(0)